161. Lipids: EPA and DHA Deep Dive with Dr. E...

Up next

443. Pulmonary Embolism: The Modern Approach to Pulmonary Embolism Care with Dr. Kenneth Rosenfield

This inaugural episode of the CardioNerds Pulmonary Embolism (PE) Series explores the evolution of acute PE care. Dr. Ibrahim Zahid, Dr. Dinu Balanescu, and Dr. Billy Joe Mullinax join guest expert Dr. Kenneth Rosenfield to discuss the shifting landscape of PE management. Pulmona ... Show more

. 25min 56sec

442. Heart Failure: LVAD Part 1 with Dr. Jeff Teuteberg and Dr. Mani Daneshmand

CardioNerds (Dr. Jenna Skowronski [Heart Failure Council Chair], Dr. Shazli Khan, and Dr. Josh Longinow) are joined by renowned leaders in the field of AHFTC (Advanced Heart Failure and Transplant Cardiology) and mechanical circulatory support, Dr. Jeff Teuteberg and Dr. Mani Dan ... Show more

. 41min 37sec

Recommended Episodes

#502: Sydney Diet-Heart Study – Is Linoleic Acid Causing Heart Disease?

Sigma Nutrition Radio

<span style= "font-size: 18pt;">Links:</span>

<ul> <li>Go to episode page (with study links)</li> <li>Subscribe to Premium</li> <li>Past episodes referen ... Show more

. 40min 52sec

#504: Vegetable Oil vs. Saturated Fat – Analysis of the LA Veterans Study

Sigma Nutrition Radio

<span style= "font-size: 18pt;">Links:</span>

<ul> <li>Go to episode page (with study links)</li> <li>Receive Sigma's email newsletter</li> <li> Show more

. 42min 57sec

#525: Cholesterol-Lowering Medication – Dr. Paddy Barrett

Sigma Nutrition Radio

Cholesterol-lowering medications, particularly statins, play a pivotal role in reducing low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) concentrations, which are causal markers in atherosclerosis development. The efficacy of these medications is well-do ...

. 48min 29sec

Episode 904: Cardiovascular Risks of Epinephrine

Emergency Medical Minute

Contributor: Aaron Lessen MD

Educational Pearls:

Epinephrine is essential in the treatment of anaphylaxis, but is epinephrine dangerous from a cardiovascular perspective?

A 2024 stud ...

. 2min 11sec